Zhi Dai
Overview
Explore the profile of Zhi Dai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
187
Citations
5605
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhu G, Tang Z, Chu T, Wang B, Chen S, Tao C, et al.
Signal Transduct Target Ther
. 2025 Jan;
10(1):25.
PMID: 39837814
Serine arginine-rich splicing factor 1 (SRSF1) is a key oncogenic splicing factor in various cancers, promoting abnormal gene expression through post-translational regulation. Although the protumoral function of SRSF1 is well-established,...
2.
Yu H, Dai Z, Zhang L, Ding C, Mohamed K, Cheng G, et al.
J Org Chem
. 2025 Jan;
90(3):1280-1287.
PMID: 39789764
Alstoschoquinolines A-D (-) representing three unprecedented scaffolds were isolated from the leaves of through direct separation by LC/MS detection. and consisted of a 5/6/5-coupled quinoline architecture containing six consecutive chiral...
3.
Zhang P, Chen S, Cai J, Song L, Quan B, Wan J, et al.
Cell Oncol (Dordr)
. 2024 Dec;
47(6):2439-2460.
PMID: 39718738
Background: Hepatocellular carcinoma (HCC) remains a significant global health challenge with limited treatment options. Lenvatinib, a tyrosine kinase inhibitor, has shown promise but is often undermined by the development of...
4.
Yu H, Ding C, Zhang L, Mohamed K, Dai Z, Wei X, et al.
Fitoterapia
. 2024 Dec;
180:106341.
PMID: 39667675
Alstoscholarisine L is an architecturally complex monoterpenoid indole alkaloid with a unique ring fusion pattern, isolated from the leaves of Alstonia scholaris. The 6/5/5/6/6/6-membered rings contain two lactonic rings and...
5.
Chen Q, Yin D, Zhang Y, Yu L, Li X, Zhou Z, et al.
Cell Death Dis
. 2024 Nov;
15(11):828.
PMID: 39543098
No abstract available.
6.
Chen S, Zhang P, Zhu G, Wang B, Cai J, Song L, et al.
Cell Mol Immunol
. 2024 Nov;
21(12):1505-1521.
PMID: 39496854
Despite the notable efficacy of anti-PD1 therapy in the management of hepatocellular carcinoma (HCC) patients, resistance in most individuals necessitates additional investigation. For this study, we collected tumor tissues from...
7.
Cai J, Song L, Zhang F, Wu S, Zhu G, Zhang P, et al.
Cancer Commun (Lond)
. 2024 Sep;
44(11):1231-1260.
PMID: 39223929
Background: The efficacy of immune checkpoint blockade therapy in patients with hepatocellular carcinoma (HCC) remains poor. Although serine- and arginine-rich splicing factor (SRSF) family members play crucial roles in tumors,...
8.
Dai Z, Liu X, Zhao Y, Zhao L, Luo X
Nat Prod Bioprospect
. 2024 Aug;
14(1):48.
PMID: 39158647
Recently the FDA conducted a risk investigation and labeled the Boxed Warning for all BCMA- and CD19-directed CAR-T cell therapy, so does it mean that the public must take risk...
9.
Fu X, Dai Z, Song K, Zhang Z, Zhou Z, Zhou S, et al.
Int J Oncol
. 2024 Jul;
65(3).
PMID: 39054958
Subsequently to the publication of the above article, an interested reader drew to the authors' attention that a possible error had been identified in the selection of images in Figs....
10.
Shi S, Wang B, Wan J, Song L, Zhu G, Du J, et al.
Acta Biochim Biophys Sin (Shanghai)
. 2024 Jun;
56(10):1571.
PMID: 38841746
No abstract available.